Rosuvastatin Is Effective to Decrease CD8 T-Cell Activation Only in HIV-Infected Patients With High Residual T-Cell Activation Under Antiretroviral Therapy. - Weiss, Laurence; Chevalier, Mathieu F.; Assoumou, Lambert; Paul, Jean-Louis; Alhenc-Gelas, Martine; Didier, Céline; Taibi, Saïd; Manea, Elena-Maria; Campa, Pauline; Girard, Pierre-Marie; Costagliola, Dominique (JAIDS: Journal of Acquired Immune Deficiency Syndromes, 2016)